{"a":[{"_":"CDMO trends reshaping biopharma manufacturing","$":{"href":"/sponsored/cdmo-trends-reshaping-biopharma-manufacturing","hreflang":"en"}}]}

Summary

Samsung Biologics discusses trends reshaping the CDMO landscape, including resilient supply chains, evolving modalities, and AI-driven manufacturing. This is sponsored content with no specific clinical, regulatory, or financial announcements.